<< Studies demonstrate that investigational cancer vaccines show encouraging immune response rates | MasterControl and i4DM to implement a quality management system for the U.S. FDA >>

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

30. October 2009 06:01

Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

"Shire is committed to the advancement of ADHD treatment research and is leading the way in developing a diverse range of safe and effective ADHD treatments," said Michael Yasick, Senior Vice President of the Shire ADHD Business Unit. "We are excited to provide new scientific data on our ADHD portfolio, which includes the newest FDA-approved ADHD treatment INTUNIV; Vyvanse, the first prodrug stimulant for the treatment of ADHD; and Daytrana, the only patch approved for the treatment of ADHD. We are proud to provide important contributions to the growing body of research on our ADHD portfolio to the medical community."

SOURCE Shire plc

90dbfda0-42c4-4824-adbb-9725dc6d8df7|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Abdominal Pain, Allergy, Anxiety, Arteriosclerosis, Bipolar Disorder, Blood Pressure, CDC, Constipation, Depression, Glaucoma, Hypersensitivity, Hyperthyroidism, Nausea, Pseudoephedrine, Psychiatry, Psychosis, Vomiting, Weight Loss

Opportunities and challenges in the psychiatric disease marketResearch and Markets has announced the addition of Decision Resources, Inc.'s new report "The Psychi...Gastroschisis may be associated with infections during pregnancyResults of an investigation conducted by University of Nevada, Reno researchers, public health offic...Want to quit smoking? Try a nicotine patch plus a nicotine lozengeIn a comparison of five different smoking cessation medications, a nicotine patch plus a nicotine lo...Shire announces new pharmacokinetic data of ADHD medicationShire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokine...Genentech releases Phase III PRIMA study findingsGenentech, Inc., a wholly-owned member of the Roche Group and Biogen Idec, today announced that a Ph...FDA approves Supplemental New Drug Application for DOXILCentocor Ortho Biotech Products, L.P. today announced that it received a Complete Response letter fr...NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drugNanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract fr...Diet pills, alcohol, caffeine, nicotine, amphetamines and cocaine abused by patients with eating disordersBetween 11 and 13 million people in the U.S. have eating disorders and at least one million will die...Stressed pregnant women more likely to have asthmatic childrenPregnant women who are stressed, particularly late in pregnancy, have an increased risk of their chi...Shire withdraws European application for Daytrana (Methylphenidate Transdermal System)Shire plc has announced that it has decided to withdraw the European Marketing Authorization Applica...Johns Hopkins safety team works to eliminate bloodstream infections in the nation and the worldA widely heralded Johns Hopkins safety initiative to reduce bloodstream infections in intensive care...Fat cell numbers in your teens set you up for lifeWhen it comes to changing your fate as far as fat is concerned the jury is still out on that particu...Antipsychotic drugs increase risk of developing pneumonia in elderlyElderly patients who use antipsychotic drugs have a 60 percent increased risk of developing pneumoni...GERD can masquerade as persistent cough or even severe chest painMany people may not realize that symptoms such as chronic cough or chest pain can be caused by acid ...Control your diabetes for lifeThe prevalence of diagnosed diabetes in U.S. adults age 20 and older has risen from about 5.1 percen...More research and innovation on child pain and stress reduction is neededRelief of pain and stress for children receiving emergency medical treatment is a vital, and readily...Wyeth gets approval for needle-less syringe for the treatment of hemophiliaWyeth Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Admini...Support for the medical use of marijuanaManhattan District Attorney Robert M. Morgenthau has announced his support for the medical use of ma...

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment

Quirky Comment Title
Name*
E-mail* (Will show your Gravatar icon)
Country Country flag

b i u quote

Comment
Preview

Notify me when new comments are added

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Recent Articles

Free!

Recent Comments

Twitter

Information

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Medical News Cloud

Recent Articles